FEPIvsLRNDETF Comparison
REX FANG & Innovation Equity Premium Income ETF
REX FANG & Innovation Equity Premium Income ETF (FEPI) belongs to the Options Strategies segment. NYLI U.S. Large Cap R&D Leaders ETF (LRND) is part of the US Large Cap segment. FEPI's top 3 sector exposures are Technology, Consumer Cyclicals and Consumer Non-Cyclicals. In contrast, LRND's top sector exposures are Technology, Healthcare and Consumer Non-Cyclicals. FEPI is more expensive with a Total Expense Ratio (TER) of 0.65%, versus 0.15% for LRND. FEPI is up 0.69% year-to-date (YTD) with +$131M in YTD flows. LRND performs better with 7.62% YTD performance, and +$294M in YTD flows. Run a side-by-side ETF comparison of FEPI and LRND below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
FEPI vs LRND performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FEPI LRND | -2.31%+1.90% | -0.66%+3.60% | +0.69%+7.62% | +12.12%+17.41% | n/a+71.88% | n/an/a |
| Flows | FEPI LRND | +$24M+$18M | +$65M+$91M | +$131M+$294M | +$257M+$353M | -+$353M | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FEPI LRND | +21.35%+17.04% | +19.11%+16.36% | n/a+17.66% | n/an/a |
| Max drawdown | FEPI LRND | -10.21%-7.87% | -12.75%-13.88% | n/a-20.97% | n/an/a |
| Max drawdown duration | FEPI LRND | 53d53d | 176d169d | n/a126d | n/an/a |
FEPI | LRND | |
Last sale 7/27/2026 at 1:30 PM | $39.60 | $43.74 |
| Previous close 07/24/2026 | $39.70 | $43.75 |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
FEPI | LRND | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
FEPI | LRND | |
|---|---|---|
| Last price | $39.60 | $43.74 |
| 1D performance | -0.25% | -0.02% |
| AuM | $656.76 M | $388.38 M |
| E/R | 0.65% | 0.15% |
FEPI | LRND | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | REX Shares | New York Life Investments |
| Benchmark | - | NYLI U.S. Large Cap R&D Leaders Index |
| N° of holdings | 16 | 732 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 11, 2023 | February 8, 2022 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
